Edwards Lifesciences Corp logo

EW

Edwards Lifesciences Corp

$99

Earnings Summary

Revenue
$1373.9Mn
Net Profits
$406.4Mn
Net Profit Margins
29.58%
PE Ratio
45.26

Highlights

Revenue:

Edwards Lifesciences Corp’s revenue fell -0.15% since last year same period to $1373.9Mn in the Q2 2022. On a quarterly growth basis, Edwards Lifesciences Corp has generated 2.44% jump in its revenue since last 3-months.

Net Profits:

Edwards Lifesciences Corp’s net profit fell -16.98% since last year same period to $406.4Mn in the Q2 2022. On a quarterly growth basis, Edwards Lifesciences Corp has generated 8.78% jump in its net profits since last 3-months.

Net Profit Margins:

Edwards Lifesciences Corp’s net profit margin fell -16.85% since last year same period to 29.58% in the Q2 2022. On a quarterly growth basis, Edwards Lifesciences Corp has generated 6.19% jump in its net profit margins since last 3-months.

PE Ratio:

Edwards Lifesciences Corp’s price-to-earnings ratio after this Q2 2022 earnings stands at 45.26.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Edwards Lifesciences Corp post its latest quarter earnings

EPS Estimate Current Quarter
0.64
EPS Estimate Current Year
0.64

Highlights

EPS Estimate Current Quarter:

Edwards Lifesciences Corp’s earning per share (EPS) estimates for the current quarter stand at 0.64 - a 0% jump from last quarter’s estimates.

EPS Estimate Current Year:

Edwards Lifesciences Corp’s earning per share (EPS) estimates for the current year stand at 0.64.

Key Ratios

Key ratios of the Edwards Lifesciences Corp post its Q2 2022 earnings

Earning Per Share (EPS)
0.63
Return on Assets (ROA)
0.13
Return on Equity (ROE)
0.26
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Edwards Lifesciences Corp’s earning per share (EPS) fell -1.56% since last year same period to 0.63 in the Q2 2022. This indicates that the Edwards Lifesciences Corp has generated -1.56% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Edwards Lifesciences Corp’s return on assets (ROA) stands at 0.13.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Edwards Lifesciences Corp’s return on equity (ROE) stands at 0.26.

Dividend Per Share (DPS):

Edwards Lifesciences Corp declared 0 dividend per share during the earnings announcement for Q2 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-07-29
0.64
0.63
-1.56%
2022-04-28
0.57
0.6
5.26%

Company Information

Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. Edwards Lifesciences is driven by a passion for patients, dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape.

Organisation
Edwards Lifesciences Corp
Headquarters
Irvine, California, US
Employees
14.9K
Industry
Health Technology
CEO
Michael Mussallem